MAPK8 and cancer: For the future of JNK targeting in cancer, we believe that this specificity can be achieved by inhibiting unique protein-protein interactions within oncogenic JNK signaling complexes, including the interactions between scaffold proteins and MAP3K/MAP2K/JNK network components.